Evidence map›Paper›PMID 36881465›Full record

Trial reportJMIR mHealth and uHealth2023

Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.

Wanja Alexander Weigandt, Yannic Schardt, Aimee Bruch, Raphael Herr, Matthias Goebeler, Johannes Benecke, Astrid Schmieder

Full text readRandomized Controlled Trial
In one paragraph

Trial report in JMIR mHealth and uHealth, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wanja Alexander WeigandtDepartment of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-3737-4087
Yannic SchardtDepartment of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-8445-7053
Aimee BruchDepartment of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-0986-0408
Raphael HerrCenter for Preventive Medicine and Digital Health Baden-Württemberg (CPD-BW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0003-0079-2792
Matthias GoebelerDepartment of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.ORCID 0000-0001-7095-9848
Johannes BeneckeDepartment of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0003-1792-9361
Astrid SchmiederDepartment of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.ORCID 0000-0002-6421-9699

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic hand and foot eczema is a polyetiological dermatological condition. Patients experience pain, itching, and sleep disturbances and have a reduced quality of life. Skin care programs and patient education can improve the clinical outcome. eHealth devices offer a new opportunity to better inform and monitor patients.

objectiveThis study aimed to systematically analyze the effect of a monitoring smartphone app combined with patient education on the quality of life and clinical outcome of patients with hand and foot eczema.

methodsPatients in the intervention group received an educational program; attended study visits on weeks 0, 12, and 24; and had access to the study app. Patients in the control group attended the study visits only. The primary end point was a statistically significant reduction in Dermatology Life Quality Index, pruritus, and pain at weeks 12 and 24. The secondary end point was a statistically significant reduction in the modified Hand Eczema Severity Index (HECSI) score at weeks 12 and 24. This is an interim analysis at week 24 of the 60-week randomized controlled study.

resultsIn total, 87 patients were included in the study and randomized to the intervention group (n=43, 49%) or control group (n=44, 51%). Of the 87 patients, 59 (68%) completed the study visit at week 24. There were no significant differences between the intervention and control groups regarding quality of life, pain, itch, activity, and clinical outcome at weeks 12 and 24. Subgroup analysis revealed that, compared with the control group, the intervention group with an app use frequency of fewer than once every 5 weeks had a significant improvement in the Dermatology Life Quality Index at weeks 12 (P=.001) and 24 (P=.05), in pain measured on a numeric rating scale at weeks 12 (P=.02) and 24 (P=.02), and in the HECSI score at week 12 (P=.02). In addition, the HECSI scores assessed on the basis of pictures taken by the patients of their hands and feet correlated strongly with the HECSI scores recorded by physicians during regular personal visits (r=0.898; P=.002) even when the quality of the images was not that good.

conclusionsAn educational program combined with a monitoring app that connects patients with their treating dermatologists can improve quality of life if the app is not used too frequently. In addition, telemedical care can at least partially replace personal care in patients with hand and foot eczema because the analysis of the pictures taken by the patients correlates strongly with that of the in vivo images. A monitoring app such as the one presented in this study has the potential to improve patient care and should be implemented in daily practice.

trial registrationDeutsches Register Klinischer Studien DRKS00020963; https://drks.de/search/de/trial/DRKS00020963.

Indexed as

EczemaMobile ApplicationsHumansPainProspective StudiesQuality of Lifedisease managementeHealthhand and foot eczemamHealthmobile healthmobile phonesmartphone apptelemedicine

Identifiers

PMID36881465
PMCPMC10031439

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read81
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.